The World Health Organisation (WHO) has announced the signing of an advance purchase agreement securing up to 40 million doses of the Pfizer-BioNTech COVID vaccine. The agreement is coming under the UN-led COVAX equitable vaccine supply programme. According to the statement, WHO’s Director-General, Dr Tedros Ghebreyesus, disclosed the plan at COVID-19 news conference at WHO headquarters in Geneva. “Together, these announcements mean COVAX could begin delivering doses in February, provided we can finalise a supply agreement. “COVAX now has agreements in place to access just over two billion doses of several promising vaccine candidates.

Source: Nigerian Tribune January 23, 2021 11:37 UTC